STOCKHOLDERS' DEFICIT (Tables)
|
3 Months Ended |
Dec. 31, 2015 |
Stockholders' Equity Note [Abstract] |
|
Schedule of stock-based compensation expense |
Stock-based
compensation expenses are generally recognized over the employees or service providers requisite service period,
generally the vesting period of the award. Stock-based compensation expense included in the accompanying statements of operations
for the three months ended December 31, 2015 and 2014 is as follows:
|
|
For the three months ended
December 31, |
|
|
|
2015 |
|
|
2014 |
|
Research |
|
|
10,400 |
|
|
|
10,400 |
|
Product Development |
|
|
9,200 |
|
|
|
18,500 |
|
Sales and marketing |
|
|
9,100 |
|
|
|
9,900 |
|
General
and administrative |
|
|
11,200 |
|
|
|
23,700 |
|
Total |
|
$ |
39,900 |
|
|
$ |
62,500 |
|
|
Schedule of stock option activity |
A
summary of stock option activity is as follows:
|
|
Number of
Shares |
|
|
Weighted
Average Exercise Price |
|
Outstanding
at September 30, 2015 |
|
|
14,230,011 |
|
|
$ |
0.75 |
|
Granted |
|
|
- |
|
|
|
|
|
Exercised |
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
- |
|
|
|
|
|
Outstanding at December
31, 2015 |
|
|
14,230,011 |
|
|
$ |
0.75 |
|
|
Schedule of the status of options outstanding |
Following
is a summary of the status of options outstanding at December 31, 2015:
Exercise Price
($) |
|
|
Number
of Shares |
|
|
Expiration
Date |
|
Weighted
Average Exercise Price ($) |
|
|
|
|
|
|
|
|
|
|
|
$ |
0.055 |
|
|
|
1,750,000 |
|
|
08/2025 |
|
$ |
0.055 |
|
|
0.04718 |
|
|
|
8,795,308 |
|
|
12/2022 01/2023 |
|
|
0.04718 |
|
|
0.25 |
|
|
|
2,715,109 |
|
|
03/2023 01/2025 |
|
|
0.25 |
|
|
0.26 |
|
|
|
425,000 |
|
|
07/2024 |
|
|
0.26 |
|
|
3.00 |
|
|
|
42,670 |
|
|
03/2022 |
|
|
3.00 |
|
|
3.60 |
|
|
|
28,648 |
|
|
08/2016 |
|
|
3.60 |
|
|
3.96 |
|
|
|
32,928 |
|
|
08/2016 |
|
|
3.96 |
|
|
9.00 |
|
|
|
4,525 |
|
|
11/2016 |
|
|
9.00 |
|
|
12.00 |
|
|
|
28,535 |
|
|
03/2019 07/2020 |
|
|
12.00 |
|
|
14.10 |
|
|
|
10,000 |
|
|
03/2021 |
|
|
14.10 |
|
|
15.30 |
|
|
|
1,373 |
|
|
09/2018 |
|
|
15.30 |
|
|
16.50 |
|
|
|
262,441 |
|
|
03/2020 |
|
|
16.50 |
|
|
17.70 |
|
|
|
953 |
|
|
08/2016 |
|
|
17.70 |
|
|
24.00 |
|
|
|
4,667 |
|
|
12/2017 |
|
|
24.00 |
|
|
26.70 |
|
|
|
32,297 |
|
|
09/2017 |
|
|
26.70 |
|
|
28.80 |
|
|
|
11,767 |
|
|
04/2018 |
|
|
28.80 |
|
$ |
32.70 |
|
|
|
83,790 |
|
|
08/2017 |
|
$ |
32.70 |
|
|
Total |
|
|
|
14,230,011 |
|
|
Average |
|
$ |
0.75 |
|
|
Schedule of share-based compensation warrants |
The
warrant activity for the period starting October 1, 2013, through December 31, 2015, is described as follows:
|
|
Number of
Shares |
|
|
Weighted
Average Exercise Price |
|
Outstanding
at September 30, 2015 |
|
|
781,524 |
|
|
$ |
0.53 |
|
Granted |
|
|
80,000,000 |
|
|
|
0.05 |
|
Exercised |
|
|
- |
|
|
|
- |
|
Expired |
|
|
(16,668 |
) |
|
|
1.00 |
|
Outstanding at December
31, 2015 |
|
|
80,764,856 |
|
|
$ |
0.054 |
|
|
Schedule of the status of warrants outstanding |
Following
is a summary of the status of warrants outstanding at December 31, 2015:
Exercise
Price |
|
|
Number
of Shares |
|
|
Expiration
Date |
|
Weighted
Average Exercise Price |
|
|
|
|
|
|
|
|
|
|
|
$ |
0.04718 |
|
|
|
38,152 |
|
|
03/2018 |
|
$ |
0.04718 |
|
|
0.05 |
|
|
|
20,000,000 |
(1) |
|
12/31/2020 |
|
|
0.05 |
|
|
0.05 |
|
|
|
60,000,000 |
(2) |
|
12/31/2020 |
|
|
0.05 |
|
|
0.25 |
|
|
|
332,200 |
|
|
04/2016 07/2017 |
|
|
0.25 |
|
|
0.275 |
|
|
|
324,000 |
|
|
06/2018 03/2019 |
|
|
0.275 |
|
|
1.00 |
|
|
|
50,502 |
|
|
10/2015 01/2017 |
|
|
1.00 |
|
|
7.50 |
|
|
|
3,334 |
|
|
05/2016 |
|
|
7.50 |
|
$ |
9.00 |
|
|
|
16,668 |
|
|
07/2017 |
|
|
9.00 |
|
|
Total |
|
|
|
80,764,856 |
|
|
|
|
$ |
0.054 |
|
|
Schedule of black-scholes option-pricing model assumption inputs |
The
Black-Scholes option-pricing model assumption inputs for December 23, 2015, valuation were as follows:
|
|
December
23, 2015 |
|
Annual dividend yield |
|
|
|
|
Expected
life (years) |
|
|
5.00 |
|
Risk-free interest
rate |
|
|
1.74 |
% |
Expected volatility |
|
|
272.56 |
% |
|